The levels of adiponectin decrease as visceral fat increases [53–56] in such conditions as central obesity, insulin resistance, and diabetes mellitus; lower adiponectin levels have notably been associated with subclinical inflammation [43]. The gene discussed is ADIPOQ; the disease is diabetes mellitus.